G-CSF动员前后外周血调节性γδ T细胞表达变化特点

来源 :广东省医学会第十七次血液病学学术会议 | 被引量 : 0次 | 上传用户:mrsouth
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:我们前期研究发现粒细胞集落刺激因子(G-CSF)动员可能影响TRGV和TRDV亚家族(γδT细胞的T细胞受体(TCR)亚家族)的TCR谱系分布和克隆性,且G-CSF动员后TRDV1亚家族表达的稳定性与移植受者移植物抗宿主病(GVHD)的低发生率呈正相关。
其他文献
目的:评估万珂联合地塞米松治疗心脏原发系统性淀粉样变性的疗效.方法:回顾性分析从2006年03月至2011年8月所有在中山大学附属第一医院确诊为系统性淀粉样变性的患者的预后.患者分为万珂联合地塞米松(VD)治疗组和无治疗组.比较两组患者的血液学、器官缓解效果以及追踪患者的生存情况.结果:10例接受VD方案化疗患者的血液学总体缓解率为80%,其中完全缓解5例,部分缓解为3例.VD方案治疗血液学缓解起
会议
Background: Engraft failure after autologous hematopoietic stem cell transplantation (auto-HSCT) is a formidable complication which occurs in 2.0-9.5% of patients and is associated with considerable m
会议
Background: Refractory acute graft versus host disease (aGVHD) is one of the major causes of death after allogenetic haematopoietic stem cell transplantation (allo-HSCT).Aims: This study evaluated the
Background: Epstein-Barr virus (EBV) infection may result in a spectrum of diseases in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), including fever, post-transplant ly
Background: Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) is a life-threatening complication that follows solid organ transplantation or allogeneic hematopoie
Background: Adult T lymphoblastic lymphoma is an aggressive form of non-Hodgkin lymphoma occurring in predominantly adolescent and young adult men.High-dose chemotherapy followed by autologous or allo
会议
Background.Myeloid sarcoma(MS) is a tumor formed by extramedullary accumulation of myeloblasts or immature myeloid cells,found in 2%-8% of patients with acute myeloid leukemia (AML).MS may develop bef
会议
Background.Allo-hematopoietic stem cell transplantation (HSCT) has been considered a prior therapeutic option in young patients with severe aplastic anaemia(SAA).The conditioning regiment often consis
会议
Objective: To investigate the effects of nicotine on the ultrastructure, proliferation, apoptosis and protein expression in human umbilical cord mesenchymal stem cells (MSCs).Methods: Human umbilical
目的:构建BCR-ABL融合基因激酶区T315I突变型和野生型质粒.材料和方法:一、材料:血液标本为在我院确诊的CML患者伊马替尼治疗2年后发生耐药,经基因测序证实存在T315I点突变的患者外周血.二、方法:1.取患者血液标本通过分离白细胞提取RNA;2.应用第一链cDNA合成试剂盒对RNA逆转录获得cDNA;3.针对T315I突变区域设计特定PCR引物,通过PCR反应大量扩增目的DNA片段;4、
会议